Heterogeneity between soluble human and rabbit splenic alpha 2-adrenoceptors

Area of Science:

• Pharmacology
• Biochemistry
• Molecular Biology

Background:

• Alpha 2-adrenoceptors play crucial roles in regulating physiological processes.
• Understanding receptor characteristics in solution is vital for drug development.
• Previous studies noted membrane-bound receptor differences between species.

Purpose of the Study:

• To investigate if membrane-bound alpha 2-adrenoceptor differences persist after solubilization.
• To explore the structural basis of any observed heterogeneity in alpha 2-adrenoceptors.
• To compare the pharmacological and biochemical properties of human and rabbit alpha 2-adrenoceptors in solution.

Main Methods:

• Solubilization of alpha 2-adrenoceptors from human and rabbit spleen plasma membranes using digitonin.
• Radioligand binding assays with [3H]yohimbine to determine receptor affinity.
• Pharmacological profiling using various agonists and antagonists.
• Assessment of protein structure via sulfhydryl modifying agents.
• Investigation of carbohydrate components using lectin affinity chromatography.

Main Results:

• Solubilization did not alter yohimbine affinity but increased idazoxan and RX 811066 potency, while decreasing prazosin, phentolamine, and WY 26392 potency.
• Agonist potencies (oxymetazoline, UK 14304, adrenaline) were reduced upon solubilization.
• Species selectivity for antagonists was maintained in solution.
• No differences in susceptibility to sulfhydryl modifying agents were found.
• Rabbit alpha 2-adrenoceptors showed lower affinity for wheat germ agglutinin and soybean lectins, indicating differences in N-acetyl d-glucosamine and N-acetyl d-galactosamine content.

Conclusions:

• Heterogeneity between human and rabbit alpha 2-adrenoceptors is likely due to intrinsic structural differences, particularly in their carbohydrate moieties.
• The membrane environment does not appear to be the primary source of observed receptor heterogeneity.
• These findings provide insights into the molecular basis of alpha 2-adrenoceptor function and potential drug interactions.